Skip to main content
Download PDF

Heparin-induced thrombocytopenia and acute colonic pseudo-obstruction after therapeutic anticoagulation in a very elderly patient with hip fracture: a case report

BMC Musculoskeletal Disorders volume 21, Article number: 85 (2020) Cite this article

Abstract

Background

Hip fractures have become a severe public health problem, especially in very elderly patients. Most of them are treated with low molecular weight heparin as prophylaxis or treatment of venous thromboembolism. Heparin-induced thrombocytopenia is one of the complications induced by low molecular weight heparin, which may cause poor prognosis. However, there is not enough awareness for heparin-induced thrombocytopenia in very elderly trauma patients.

Case presentation

We report a case of hip fracture with heparin-induced thrombocytopenia in a very elderly patient. The patient developed heparin-induced thrombocytopenia, digestive hemorrhage and acute colonic pseudo-obstruction after the use of low molecular weight heparin, which eventually led to death.

Conclusions

This is the first case report of digestive hemorrhage and acute colonic pseudo-obstruction in heparin-induced thrombocytopenia patients with major trauma. This case highlights the severity of HIT in very elderly patients with hip fractures using low molecular weight heparin, and the need for platelet monitoring in these patients. We indicate that there may be a correlation of pathogenesis between digestive hemorrhage and acute colonic pseudo-obstruction in heparin-induced thrombocytopenia patients.

Peer Review reports

Background

As the number of elderly increases, hip fractures become a severe public health problem, especially in very elderly patients [1]. The preoperative incidence of venous thromboembolism in hip fracture patients is approximately 18.4–19.5% [2, 3]. Several current guidelines recommend low molecular weight heparin (LMWH) as an optimal form of venous thromboembolism (VTE) prophylaxis or treatment in patients with hip fractures [4,5,6]. Very elderly (age > 80 years) trauma patients have worse general conditions and higher risks of heparin related complications, which may lead to poor prognosis [7,8,9]. However, HIT in very elderly trauma patients does not receive enough attention. We report a case of hip fracture in a very elderly patient who developed serious complications, such as HIT, digestive hemorrhage and acute colonic pseudo-obstruction (ACPO) after the use of LMWH. We obtained consent for publication from the patient's son.

Case presentation

An 84-year-old male patient fell while walking and suffered left intertrochanteric fracture (Fig. 1). He refused the surgery recommendation, chose to remain bedridden. Physical therapy for prophylaxis of thromboembolism at home was prescribed. Ten days later, his left calf swelled, and venous thrombosis was identified by ultrasound in popliteal vein and posterior tibial veins. The patient was admitted to our department 13 days after the injury to evaluate and improve medical fitness and prepare for internal fixation. The patient had a medical history of cerebral infarction more than 10 years ago, and long-term use of aspirin. The platelet count was 349 × 10^9/L, and the haemoglobin count was 112 g/L on the first day of admission (Table 1). Aspirin was stopped and LMWH (FRAGMIN, Pfizer) 5000 IU was given twice daily as therapeutic anticoagulation therapy. Moreover, the inferior vena cava filter was placed. Unfortunately, serious blood shortage happened which led to the postponement of the internal fixation. The patient had abdominal distention and melena on the 16th day after admission (Table 1). He developed hematochezia 3 h later without peritoneal irritation. Redness and swelling were found at the LMWH injection site. The platelet count was 3 × 10^9/L, and the haemoglobin count was 98 g/L. The sum of the 4 T’s scores was 6. Autoantibodies, anti-ds DNA antibody, and other tests for differential diagnosis were normal. Therefore, we made the clinical diagnosis of HIT, digestive hemorrhage, VTE, and intertrochanteric fracture. We stopped LMWH therapy and underwent gamma globulin infusion (0.4 g/kg, iv), methylprednisolone infusion (60 mg, iv, QD), platelet transfusion and total parenteral nutrition (TPN). After that, the platelet count increased steadily, and the digestive haemorrhage gradually stopped. On the 24th day after admission (Table 1) (the 5th day of the use of gamma globulin) the platelet count recovered to 60 × 10^9/L, and the haemoglobin count recovered to 96 g/L. On the 35th day after admission (Table 1), the patient developed abdominal distending pain. Physical examination indicated the weakening of bowel sounds without abdominal tenderness. The platelet count was 87 × 10^9/L. The haemoglobin count was 108 g/L. The WBC count was 12.8 × 109/L, and the potassium concentration was 5.59 mmol/L. Abdominal X-ray showed colonic dilatation. The abdominal CT scan showed colonic dilatation with no sign of thromboses and mechanical obstruction, such as thickening of the colonic wall or thrombosis of mesenteric vessels (Fig. 2). Therefore, we performed a multidisciplinary consultation and made a diagnosis of ACPO and performed conservative treatments, such as TPN and gastrointestinal decompression therapy. On the 39th day after admission (Table 1), the patient developed high fever and unconsciousness without acute abdominal pain and tenderness. The platelet count was 14 × 10^9/L. The haemoglobin count was 95 g/L, and the WBC count was 4.8 × 109/L. The serum lactate was 4.0 mmol/l, the blood pressure was 90/63 mmHg, and heart rate was 98 beats per minute, which suggested of septic shock. We diagnosed the patient with gut-origin septic shock and micro-angiopathic hemolysis. The conservative treatments, such as gastrointestinal decompression, TPN, anti-infection and somatostatin were ineffective, and the patient died 4 days later.

Fig. 1
figure1

X-ray indicated left intertrochanteric fracture

Full size image
Table 1 Summary of the laboratory results
Full size table
Fig. 2
figure2

Abdominal CT scan showed colonic dilatation with no sign of thromboses and mechanical obstruction

Full size image

Discussion and conclusions

HIT is a clinical complication after exposure to heparin for approximately 5–14 days, which results from antibodies directed against antigenic complexes of platelet factor 4 and heparin [10]. Patients exposed to LMWH seldom develop HIT with an incidence rate of approximately 0.2–0.54% [11, 12]. The platelet count is rarely less than 15,000/μL [13]. Only approximately 2.7% of HIT patients develop digestive hemorrhage [14]. Elderly patients with hip fracture or surgery rarely develop ACPO with an estimated prevalence of 0.067–0.29% [15,16,17] indicating that this case is very rare, and these complications might not be independent. This is the first known case report about the combination of digestive hemorrhage and ACPO in HIT patients.

This case indicates that very elderly trauma patients may have a worse prognosis. As literature documented, comorbidities might contribute to the development or exacerbation of HIT. Sun X et al. [18] found that HIT is more likely to happen in patients with clinical heart failure and increased body mass index. Joseph et al. [19] found that acutely ill medical patients are at higher risk of HIT, and HIT-related major bleeding risk will increase in patients in critical care units and dialysis dependent.

It remains controversial whether platelet count monitoring is necessary on isolated HIT patients. In the guidelines of the American College of Chest Physicians (ACCP) [20], protocols of platelet count monitoring in patients using heparin are based on the incidence of HIT. The patient population is divided into the postoperative group and medical patients group according to the incidence of HIT. This classification excludes preoperative elderly patients with major trauma, such as hip fractures. However, these patients usually have more comorbidities and worse surgical tolerance [8]. Therefore, it takes longer to evaluate and improve medical fitness for the procedure. Moreover, according to the American Society of Hematology 2018 guidelines [21], patients receiving LWMH after major trauma belong to intermediate-risk group, and platelet count monitoring every 2 to 3 days was recommended. However, it is a conditional recommendation with very low certainty evidence. This case indicates that very elderly trauma patients may have a worse prognosis of HIT than younger patients. Therefore, a routine analysis platelet count may be necessary for these patients.

It is still controversial whether additional non-heparin anticoagulant should be used in patients with isolated HIT and digestive bleeding after discontinuation of heparin. The most common complication of HIT is thrombosis, with an incidence of more than 50% [20, 22]. Therefore, it is difficult to strike the risk-benefit balance of bleeding control and thrombosis prophylaxis. The 9th American College of Chest Physicians evidence-based clinical practice guideline recommends the use of lepirudin or argatroban or danaparoid over the discontinuation of heparin. However, it remains uncertain whether non-heparin anticoagulant will increase the risk of major bleeding [20]. The American Society of Hematology guideline panel recommends reducing the non-heparin anticoagulant intensity from therapeutic to prophylactic if the patient is at high risk of bleeding [21]. We did not initiate non-heparin anticoagulant because of severe digestive hemorrhage. We hypothesise that the absence of non-heparin anticoagulant might lead to a risk of micro-thrombosis and hypoperfusion of the bowel wall, which might led to ACPO. Therefore, we suggest further study to clarify the relationship between the discontinuation of heparin and ACPO.

ACPO is a rare clinical syndrome characterised by acute colonic dilatation without mechanical obstruction [15, 23]. The imbalance of the autonomic nervous system nervous is the universal pathogenesis theory of ACPO. Other studies suggest that ACPO might be related to hypoperfusion, abnormal hormone levels and decreases in pacemaker cells [15, 23]. This patient had a platelet transfusion history and did not have an additional non-heparin anticoagulant after discontinuation of heparin, which led to a higher risk of thrombosis. We hypothesise that hypoperfusion caused by micro-thrombosis and a decrease in pacemaker cells caused by digestive haemorrhage may play a role in the development of ACPO. However, trauma and being bedridden long-term may also lead to the imbalance of the autonomic nervous system [17]. Therefore, HIT and ACPO, in this case, might be two independent complications. In any case, we suggest future studies to focus more on links between ACPO and HIT trauma patients.

In conclusion, this is the first case report of digestive hemorrhage and acute colonic pseudo-obstruction in heparin-induced thrombocytopenia patients with major trauma. This case suggests that HIT in very elderly trauma patients might cause severe complications, such as gastrointestinal bleeding and ACPO, which would lead to poor prognosis. Therefore, we suggest a routine analysis of plate count in the very elderly patients with major trauma, and an interdisciplinary approach might be needed in the case of HIT. Moreover, there may be correlations in pathogenesis between digestive hemorrhage and ACPO in trauma patients with HIT.

Availability of data and materials

The datasets in this case report are not publicly available due to the protection of patient’s information. However, the reasonable requests will be met by the corresponding author.

Abbreviations

ACPO:

Acute colonic pseudo-obstruction

HIT:

Heparin-induced thrombocytopenia

LMWH:

Low molecular weight heparin

TPN:

Total parenteral nutrition

VTE:

Venous thromboembolism

References

  1. 1.

    Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: worldwide geographic variation. Indian J Orthop. 2011;45(1):15–22.

    Article  Google Scholar 

  2. 2.

    Park JS, Jang JH, Park KY, Moon NH. High energy injury is a risk factor for preoperative venous thromboembolism in the patients with hip fractures: a prospective observational study. Injury. 2018;49(6):1155–61.

    Article  Google Scholar 

  3. 3.

    Li Q, Dai B, Xu J, Yao Y, Song K, Zhang H, Chen D, Jiang Q. Can patients with femoral neck fracture benefit from preoperative thromboprophylaxis?: a prospective randomized controlled trial. Medicine. 2017;96(29):e7604.

    Article  Google Scholar 

  4. 4.

    Brox WT, Roberts KC, Taksali S, Wright DG, Wixted JJ, Tubb CC, Patt JC, Templeton KJ, Dickman E, Adler RA, et al. The American Academy of Orthopaedic Surgeons Evidence-Based Guideline on Management of Hip Fractures in the Elderly. J Bone Joint Surg Am. 2015;97(14):1196-9.

    Article  Google Scholar 

  5. 5.

    Sagi HC, Ahn J, Ciesla D, Collinge C, Molina C, Obremskey WT, Guillamondegui O, Tornetta P 3rd. Venous thromboembolism prophylaxis in orthopaedic trauma patients: a survey of OTA member practice patterns and OTA expert panel recommendations. J Orthop Trauma. 2015;29(10):e355–62.

    Article  Google Scholar 

  6. 6.

    Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, Brekelmans MPA, Buller HR, Elias A, Farge D, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208–18.

    CAS  Article  Google Scholar 

  7. 7.

    Campbell NR, Hull RD, Brant R, Hogan DB, Pineo GF, Raskob GE. Aging and heparin-related bleeding. Arch Intern Med. 1996;156(8):857–60.

    CAS  Article  Google Scholar 

  8. 8.

    Lubenow N, Hinz P, Thomaschewski S, Lietz T, Vogler M, Ladwig A, Junger M, Nauck M, Schellong S, Wander K, et al. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. Blood. 2010;115(9):1797–803.

    CAS  Article  Google Scholar 

  9. 9.

    Haas LEM, van Beusekom I, van Dijk D, Hamaker ME, Bakhshi-Raiez F, de Lange DW, de Keizer NF. Healthcare-related costs in very elderly intensive care patients. Intensive Care Med. 2018;44(11):1896–903.

    CAS  Article  Google Scholar 

  10. 10.

    Lee GM, Arepally GM. Diagnosis and management of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am. 2013;27(3):541–63.

    Article  Google Scholar 

  11. 11.

    Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005;106(8):2710–5.

    CAS  Article  Google Scholar 

  12. 12.

    Stein PD, Hull RD, Matta F, Yaekoub AY, Liang J. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. Am J Med. 2009;122(10):919–30.

    Article  Google Scholar 

  13. 13.

    Warkentin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol. 1998;35(4 Suppl 5):9–16 discussion 35-16.

    CAS  PubMed  Google Scholar 

  14. 14.

    Goel R, Ness PM, Takemoto CM, Krishnamurti L, King KE, Tobian AA. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood. 2015;125(9):1470–6.

    CAS  Article  Google Scholar 

  15. 15.

    Pereira P, Djeudji F, Leduc P, Fanget F, Barth X. Ogilvie’s syndrome-acute colonic pseudo-obstruction. J Visc Surg. 2015;152(2):99–105.

    CAS  Article  Google Scholar 

  16. 16.

    Deleanu B, Prejbeanu R, Vermesan D, Haragus H, Icma I, Predescu V. Acute abdominal complications following hip surgery. Chirurgia (Bucur). 2014;109(2):218–22.

    CAS  Google Scholar 

  17. 17.

    Clarke HD, Berry DJ, Larson DR. Acute pseudo-obstruction of the colon as a postoperative complication of hip arthroplasty. J Bone Joint Surg Am. 1997;79a(11):1642–7.

    Article  Google Scholar 

  18. 18.

    Sun X, Hill PC, Taylor-Pane KS, Corso PJ, Lindsay J. Heparin-induced thrombocytopenia in contemporary cardiac surgical practice and experience with a protocol for early identification. Am J Cardiol. 2016;117(2):305–9.

    CAS  Article  Google Scholar 

  19. 19.

    Joseph L, Casanegra AI, Dhariwal M, Smith MA, Raju MG, Militello MA, Gomes MP, Gornik HL, Bartholomew JR. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia. J Thromb Haemost. 2014;12(7):1044–53.

    CAS  Article  Google Scholar 

  20. 20.

    Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e278S–325S.

    CAS  Article  Google Scholar 

  21. 21.

    Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, et al. American society of hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360–92.

    CAS  Article  Google Scholar 

  22. 22.

    Salter BS, Weiner MM, Trinh MA, Heller J, Evans AS, Adams DH, Fischer GW. Heparin-induced thrombocytopenia: a comprehensive clinical review. J Am Coll Cardiol. 2016;67(21):2519–32.

    CAS  Article  Google Scholar 

  23. 23.

    Wells CI, O'Grady G, Bissett IP. Acute colonic pseudo-obstruction: a systematic review of aetiology and mechanisms. World J Gastroenterol. 2017;23(30):5634–44.

    Article  Google Scholar 

Download references

Acknowledgements

I appreciated Dr. Lin for her support and understanding.

Funding

The Beijing Municipal Science and Technology Project, Z181100001718159. The funding body will support the publication fees without affecting the diagnosis and treatment of the patient, and the writing of manuscript.

Author information

Affiliations

  1. Department of Orthopaedics and Trauma, Peking University People’s Hospital, Beijing, 100044, China

    Yijun Liu, Hao Lu, Hailin Xu, Zhongguo Fu, Dianying Zhang & Baoguo Jiang

Authors
  1. Yijun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hao Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hailin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhongguo Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dianying Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Baoguo Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YL performed the data collection and wrote the manuscript. HL performed the literature search, reviewed the literature, and edited the manuscript. ZF collected the data and edited the manuscript. HX, DZ and BJ contributed to the collected the data and guaranteed of the integrity of the entire study. All authors have read and approved the manuscript.

Authors’ information

Not applicable.

Corresponding authors

Correspondence to Hailin Xu or Dianying Zhang or Baoguo Jiang.

Ethics declarations

Ethics approval and consent to participate

This case report has been conducted according to the standards of the Declaration of Helsinki. The written content to publish was obtained from the patient’s son.

Consent for publication

The written content to publish was obtained from the patient’s son.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Lu, H., Xu, H. et al. Heparin-induced thrombocytopenia and acute colonic pseudo-obstruction after therapeutic anticoagulation in a very elderly patient with hip fracture: a case report. BMC Musculoskelet Disord 21, 85 (2020). https://doi.org/10.1186/s12891-020-3117-8

Download citation

Keywords

  • Hip fracture
  • Low molecular weight heparin
  • Heparin-induced thrombocytopenia
  • Digestive hemorrhage
  • Acute colonic pseudo-obstruction
  • Case report

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us